Press Play with Madeleine Brand
UCLA doctor on leading Remdesivir trials as possible COVID-19 treatment
The National Institutes of Health is sponsoring 75 clinical trials across the world for a possible treatment for COVID-19. They’re all testing a drug called Remdesivir, which was originally developed as treatment for Ebola.
By Madeleine Brand • • 1 min readThe National Institutes of Health is sponsoring 75 clinical trials across the world for a possible treatment for COVID-19. They’re all testing a drug called Remdesivir, which was originally developed as treatment for Ebola. Some of those trials are happening at UCSF, Stanford and UCLA. We speak with UCLA’s Dr. Otto Yang, who’s heading the trial.
The full episode
1 of 5
COVID-19 caregiving at home- 0:00UCLA doctor on leading Remdesivir trials as possible COVID-19 treatmentYou’re reading this
- 9:14Retired doctor jumps back into his scrubs to help COVID-19 patients in California
- 16:20How to take care of someone with COVID-19 at home
- 23:49Hollywood in virtual quarantine: What life’s like for industry workers
- 37:00‘Slay the Dragon’ documentary: How activists beat partisan gerrymandering in US
The full episode
1 of 5COVID-19 caregiving at home- 0:00UCLA doctor on leading Remdesivir trials as possible COVID-19 treatmentYou’re reading this
- 9:14Retired doctor jumps back into his scrubs to help COVID-19 patients in California
- 16:20How to take care of someone with COVID-19 at home
- 23:49Hollywood in virtual quarantine: What life’s like for industry workers
- 37:00‘Slay the Dragon’ documentary: How activists beat partisan gerrymandering in US